| Marie Ida Bakou, | |
|
6949 S 110th St, La Vista, NE 68128-5721 | |
| (402) 597-4947 | |
| Not Available |
| Full Name | Marie Ida Bakou |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 6949 S 110th St, La Vista, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194413138 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 26147 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marie Ida Bakou, 6949 S 110th St, La Vista, NE 68128-5721 Ph: (402) 597-4947 | Marie Ida Bakou, 6949 S 110th St, La Vista, NE 68128-5721 Ph: (402) 597-4947 |
News Archive
Self-organization keeps schools of fish, flocks of birds and colonies of termites in sync. It's also, according to new research, the way cells regulate the final stage of cell division. Scientists at Rockefeller University have shown that a protein-chemistry-based contour map, which helps individual proteins locate the center of their cell without direction from a 'master organizer,' is key to ensuring accurate division during mitosis.
The Michigan Legislature today delivered a historic victory for health and the public's right to breathe clean air by passing legislation to make almost all workplaces, including all restaurants and bars, smoke-free. Gov. Jennifer Granholm has said she will sign the bill, which will make Michigan the 27th state to pass a strong smoke-free law that includes all restaurants and bars.
Sigma Tau Pharma Ltd. (hereinafter referred to as Sigma-Tau Rare Disease), today announced the submission of an application to the European Medicines Agency for use of its pegylatedL-asparaginase, Oncaspar (pegaspargase) for the treatment of Acute Lymphoblastic Leukaemia (ALL) as part of a multi-agent chemotherapeutic regimen.
Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.
A review of scientific studies that compares two treatments for preventing strokes due carotid artery disease provides no clear answer on which treatment is better, a UT Southwestern Medical Center physician reports in an editorial in today's issue of the Archives of Internal Medicine.
› Verified 2 days ago
Michele Hardin, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6949 S 110th St, La Vista, NE 68128 Phone: 402-597-4947 | |
Heidi Andsager, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6949 S 110th St, La Vista, NE 68128 Phone: 402-597-4947 | |
Caren Linn Starlin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7900 Edgewood Blvd, La Vista, NE 68128 Phone: 402-898-0436 | |
Brianna Stephen, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6949 S 110th St, La Vista, NE 68128 Phone: 402-597-4941 |